Department of Gastroenterology Hospital, St Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland.
Eur J Gastroenterol Hepatol. 2013 May;25(5):550-5. doi: 10.1097/MEG.0b013e32835d4e9c.
Magnetic resonance enterography (MRE) is a relatively new imaging modality that involves small bowel distension with orally administered fluid. Few studies have assessed its impact on patient management.
The aim of this study was to determine whether MRE influenced the management of patients with established small bowel Crohn's disease (CD).
From a prospectively maintained database of patients with inflammatory bowel disease, we identified patients with small bowel CD who underwent MRE between January 2007 and December 2010. The results of the MRE and subsequent changes in patient management within 1 month were evaluated.
Thirty women and 27 men with CD were included. Seven patients (12%) had a normal MRE. Forty-two of 57 (74%) patients had a change in management, and 41/50 (82%) patients with an abnormal MRE had changes in management (P<0.0008). After MRE, 20/42 (47%) patients had surgery and 22/42 (53%) had changes in medical treatment. Patients with stricturing disease had more surgical intervention (P=0.02), and patients with active disease on MRE had more medical intervention (P=0.0001). Patients with two or more abnormalities on MRE had more surgery compared with medical therapy (P=0.02).
The majority of patients with small bowel CD had a change in management as a result of the MRE. Because of its high clinical impact on patient management, MRE should become one of the preferred methods of small bowel evaluation in CD. Specific MRE findings may help to stratify treatment options, however, further work is required to validate this.
磁共振肠造影(MRE)是一种相对较新的成像方式,涉及口服液体扩张小肠。很少有研究评估其对患者管理的影响。
本研究旨在确定 MRE 是否影响已确诊的小肠克罗恩病(CD)患者的管理。
我们从炎症性肠病患者的前瞻性数据库中,确定了 2007 年 1 月至 2010 年 12 月期间接受 MRE 的小肠 CD 患者。评估了 MRE 的结果以及 1 个月内患者管理的后续变化。
纳入 30 名女性和 27 名男性 CD 患者。7 名患者(12%)MRE 正常。42/57(74%)患者管理发生变化,41/50(82%)异常 MRE 患者管理发生变化(P<0.0008)。MRE 后,20/42(47%)例患者接受手术,22/42(53%)例患者接受药物治疗变化。狭窄性疾病患者手术干预更多(P=0.02),MRE 活动性疾病患者药物干预更多(P=0.0001)。MRE 有两个或更多异常的患者手术治疗比药物治疗更多(P=0.02)。
大多数小肠 CD 患者由于 MRE 而改变了治疗方案。由于 MRE 对患者管理具有很高的临床影响,因此它应该成为 CD 小肠评估的首选方法之一。特定的 MRE 发现可能有助于分层治疗选择,但需要进一步工作来验证这一点。